The Institute serves as a catalyst for global collaboration,
working with partners across the University of North Carolina and around the world.
There’s Still A Lot We Don’t Know
We have learned much about COVID-19 but there are still important questions to be answered about who is at risk for infection, how well vaccines and treatments work over time, and Long COVID, among others. Watch the video at left to learn more.
Cindy Gay, MD, on leading COVID-19 vaccine trial; Ron Falk, MD, on participating
Michelle Floris-Moore, MD, MS, talks about impact of COVID-19 on African Americans
Michael Herce, MD, MPH, MSc: ¿Por qué participar en un esayo clinico?
Emerging Pathogen Preparedness and Training:
Infectious Diseases and critical care experts William Fischer, MD, and David Wohl, MD, in collaboration with UNC Hospitals colleagues,will lead a Regional Emerging Special Pathogen Treatment Center funded through the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response
Many courageous infectious disease specialists and other clinicians have not shied away from caring for those in need, even in the hot zones.These efforts require clever and creative work, like the kind demonstrated during the COVID-19 pandemic. A pop-up Respiratory Diagnosis Clinic (RDC) went up over a weekend, travel down North Carolina’s back roads took COVID testing into rural areas, and as remarkable, UNC’s state of the art Surveillance Laboratory was built in 9 weeks, becoming Carolina’s frontline defense again Covid. Now, UNC will become a regional expert in civilian biodefense, joining Emory University, as the only two RESPTCs in the Southeast. “We go into Liberia, we go into the Lassa fever unit,” said Wohl. “Billy Fischer is a world expert on Ebola management. We jumped in right away to see patients exposed to mpox. And when COVID started and people were scared, we helped, with many others, to lead the way. We know how to do this. This is what we do.”
Read story
2018-2020 Impact Report:
Pandemic highlights Institute’s critical role
Our abbreviated report includes updates from the Institute’s global sites, stats on the breadth and impact of our work, and a look at the COVID-19 research that our faculty launched in the spring of 2020 in reaction to the pandemic.
Download impact report
Now More Than Ever, Global is Local
Latest Institute news
-
I AM IGHID: Erin Hoffman
Erin Hoffman is the Operations Manager for the Institute’s Chapel Hill Clinical Research Site (CRS), one of four research sites supporting IGHID’s Clinical Trials Unit. She learned about HIV from two people who were living openly with the disease, and it was their inspiring stories that would later influence her career path. In her free time, Erin … Continued
-
HIV Research in the Time of COVID: Chunyan Li Studies Barriers to PrEP in Guangdong and a Unique Intervention
Chunyan Li is a social and behavioral researcher in the Department of Health Behavior at the Gillings School of Global Public Health applying socially innovative and community-engaged approaches to promote public health in global settings. For her dissertation, she worked with UNC Project-China to assess barriers to PrEP in the province of Guangdong. She also tested … Continued
-
Friday Saidi Receives Scientific Achievement Awards
Friday Saidi, MBBS, MMED, is first author of two papers published in 2021, that received Scientific Achievement Awards at UNC Malawi. The papers include: Term gravid uterus in a congenital umbilical hernia: a case report, published in the Journal of Medical Case Reports. Contributing IGHID authors include: Maganizo Chagomerana, PhD, Lameck Chinula, MD, and Jennifer Tang, MD, MSCR … Continued